Serum Institute gets nod for human clinical trials of vaccine
The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting Phase II and Phase III and
August 3, 2020
The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting Phase II and Phase III and
The race is underway across the world to find a medicine or vaccines to fight COVID-19. Russia has already claimed to be the first country